Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study

BACKGROUND: Despite the chronicled success of low-density lipoprotein cholesterol (LDLc)-lowering statin therapy, substantial residual cardiovascular (CV) disease risk remains a problem worldwide, highlighting the need to for combination therapies targeting non-LDLc factors, such as with fenofibrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Taek-Geun, Jang, Albert Youngwoo, Kim, Sang Wook, Hong, Young Joon, Bae, Jang-Ho, Lee, Sung Yun, Kim, Sang-Hyun, Han, Seung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178941/
https://www.ncbi.nlm.nih.gov/pubmed/32321551
http://dx.doi.org/10.1186/s13063-020-04291-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178941/
https://www.ncbi.nlm.nih.gov/pubmed/32321551
http://dx.doi.org/10.1186/s13063-020-04291-5

Ejemplares similares